Listed

DuPont de Nemours, Inc.: Form 10-Q for the period ended Jun 30, 2018

Filed with the SEC on Aug 3, 2018 and accepted by EDGAR at Aug 3, 2018, 09:19 ET.

Share

Management's discussion and analysis

As filed, 119,781 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

On December 11, 2015, The Dow Chemical Company ("Dow") and E. I. du Pont de Nemours and Company ("DuPont") entered into an Agreement and Plan of Merger ("Merger Agreement"), as amended on March 31, 2017, to effect an all-stock merger of equals strategic combination resulting in a newly formed corporation named DowDuPont Inc. ("DowDuPont" or the "Company"). On August 31, 2017, pursuant to the Merger Agreement, Dow and DuPont each merged with wholly owned subsidiaries of DowDuPont ("Mergers") and, as a result of the Mergers, Dow and DuPont became subsidiaries of DowDuPont (collectively, the "Merger"). Prior to the Merger, DowDuPont did not conduct any business activities other than those required for its formation and matters contemplated by the Merger Agreement. Dow was determined to be the accounting acquirer in the Merger. As a result, the historical financial statements of Dow for the periods prior to the Merger are considered to be the historical financial statements of DowDuPont. The results of DuPont are included in DowDuPont's consolidated results from the Merger date forward.

DowDuPont intends to pursue, subject to the receipt of approval by the Board of Directors ("Board") of DowDuPont and customary closing conditions, the separation of the combined Company's agriculture, materials science and specialty products businesses through one or more tax-efficient transactions ("Intended Business Separations").

Except as otherwise indicated by the context, the term "Dow" includes Dow and its consolidated subsidiaries, "DuPont" includes DuPont and its consolidated subsidiaries, "Union Carbide" means Union Carbide Corporation, a wholly owned subsidiary of Dow, and "Dow Silicones" means Dow Silicones Corporation (formerly known as Dow Corning Corporation, which changed its name effective as of February 1, 2018), a wholly owned subsidiary of Dow.

Items Affecting Comparability of Financial Results

Due to the size of each of Dow's and DuPont's businesses prior to the Merger, in this section certain supplemental unaudited pro forma financial information is provided that assumes the Merger had been consummated on January 1, 2016. Adjustments have been made in the unaudited pro forma financial information for (1) the preliminary purchase accounting impact, (2) accounting policy alignment, (3) the elimination of the effect of events that are directly attributable to the Merger Agreement (e.g., one-time transaction costs), (4) the elimination of the impact of transactions between Dow and DuPont, and (5) the elimination of the effect of consummated divestitures required as a condition of regulatory approval for the Merger. Events that are not expected to have a continuing impact on the combined results (e.g., inventory step-up costs) are excluded. These adjustments impacted the consolidated results as well as the reportable segments. For additional information, see the Supplemental Unaudited Pro Forma Combined Financial Information in this section.

OVERVIEW

The following is a summary of the results from continuing operations for the three months ended June 30, 2018:

  • The Company reported net sales in the second quarter of 2018 of $24.2 billion, up 75 percent from $13.8 billion in the second quarter of 2017. Portfolio & Other contributed 61 percent of the sales increase (62 percent increase from the Merger, impacting all segments except Performance Materials & Coatings and Industrial Intermediates & Infrastructure, offset by a 1 percent decrease from other portfolio actions). The remainder of the increase was driven by broad-based sales growth across all segments and geographic regions.
  • Volume increased 7 percent compared with the second quarter of 2017, with increases in all operating segments, except Nutrition & Biosciences (flat), including a double-digit increase in Industrial Intermediates & Infrastructure (up 18 percent). Volume increased in all geographic regions, led by a double-digit increase in Asia Pacific (up 18 percent).
  • Local price was up 4 percent compared with the same period last year, driven primarily by broad-based pricing actions in response to higher feedstock and raw material costs. Local price increased in Performance Materials & Coatings (up 10 percent), Industrial Intermediates & Infrastructure (up 8 percent), Nutrition & Biosciences (up 3 percent), Packaging & Specialty Plastics (up 2 percent) and Safety & Construction (up 1 percent) and declined in Electronics & Imaging (down 1 percent). Price was flat in Agriculture and Transportation & Advanced Polymers. Local price increased in all geographic regions.
  • Currency had a favorable impact of 3 percent on sales, driven primarily by Europe, Middle East and Africa ("EMEA").
  • Research and development ("R&D") expenses totaled $803 million in the second quarter of 2018, up from $408 million in the second quarter of 2017. Selling, general and administrative ("SG&A") expenses were $1,933 million in the second quarter of 2018, up from $720 million in the second quarter of 2017. R&D and SG&A expenses increased primarily due to the Merger.
  • Restructuring and asset related charges (credits) - net was a $189 million charge in the second quarter of 2018, consisting of $114 million of severance and related benefit costs, $33 million of asset write-downs and write-offs and $42 million of costs associated with exit and disposal activities.
  • Integration and separation costs were $558 million in the second quarter of 2018, up from $136 million in the second quarter of 2017, primarily from post-Merger integration and Intended Business Separation activities.
  • Equity in earnings of nonconsolidated affiliates was $250 million in the second quarter of 2018, up from $54 million in the second quarter of 2017, primarily due to higher earnings from the Kuwait joint ventures and lower equity losses from Sadara Chemical Company ("Sadara").
  • Sundry income (expense) - net was income of $178 million in the second quarter of 2018, down from income of $322 million in the second quarter of 2017 which included a gain related to the Nova patent infringement award.
  • On April 25, 2018, DowDuPont announced that its Board declared a dividend of $0.38 per share, which was paid on June 15, 2018, to shareholders of record on May 31, 2018.
  • On June 25, 2018, DowDuPont announced that its Board declared a dividend of $0.38 per share, payable on September 14, 2018, to shareholders of record on August 31, 2018.
  • The Company spent $1 billion on repurchases of DowDuPont common stock in the second quarter of 2018. At June 30, 2018, $1 billion of the $4 billion share repurchase program authorization remained available for additional purchases. Although there is no timeline to complete the share repurchase program, subject to sufficient opportunities to be in the market, DowDuPont intends to repurchase approximately $1 billion of the Company's stock in the third quarter of 2018, thereby completing the share repurchase program.

In addition to the financial highlights above, the following event occurred subsequent to the second quarter of 2018:

  • Andrew N. Liveris, former Executive Chairman of DowDuPont, retired on July 1, 2018.

In millions, except per share amounts

Selected Financial Data Three Months Ended Jun 30, 2018 Jun 30, 2017 Six Months Ended Jun 30, 2018 Jun 30, 2017
Net sales $24,245 $13,834 $45,755 $27,064
Cost of sales ("COS") $17,974 $10,761 $34,289 $20,955
Percent of net sales 74.1% 77.8% 74.9% 77.4%
Research and development expenses $803 $408 $1,571 $827
Percent of net sales 3.3% 2.9% 3.4% 3.1%
Selling, general and administrative expenses $1,933 $720 $3,647 $1,479
Percent of net sales 8.0% 5.2% 8.0% 5.5%
Effective tax rate 23.9% 25.1% 24.4% 22.7%
Net income available for common stockholders $1,768 $1,321 $2,872 $2,209
Earnings per common share – basic $0.76 $1.08 $1.24 $1.82
Earnings per common share – diluted $0.76 $1.07 $1.23 $1.79

50

RESULTS OF OPERATIONS

In millions

Summary of Sales Results Three Months Ended Jun 30, 2018 Jun 30, 2017 Six Months Ended Jun 30, 2018 Jun 30, 2017
Net sales $24,245 $13,834 $45,755 $27,064
Pro forma net sales $20,717 $41,184

As Reported Net Sales in the Current Period Compared with As Reported Net Sales in the Prior Period

Sales Variances by Segment and Geographic Region - As Reported

Percentage change from prior year Three Months Ended Jun 30, 2018 Local Price & Product Mix Currency Volume Portfolio & Other 1 Total Six Months Ended Jun 30, 2018 Local Price & Product Mix Currency Volume Portfolio & Other 1 Total
Agriculture —% 2% 2% 248% 252% —% 3% (3)% 198% 198%
Performance Materials & Coatings 10 3 1 — 14 10 3 (1) 1 13
Industrial Intermediates & Infrastructure 8 3 18 — 29 10 4 16 — 30
Packaging & Specialty Plastics 2 3 8 7 20 1 3 9 7 20
Electronics & Imaging (1) 1 5 73 78 — 1 3 73 77
Nutrition & Biosciences 3 3 — 535 541 3 4 4 543 554
Transportation & Advanced Polymers — 3 6 384 393 — 4 3 385 392
Safety & Construction 1 3 3 181 188 1 3 — 189 193
Total 4% 3% 7% 61% 75% 4% 3% 6% 56% 69%
U.S. & Canada 3% —% 6% 89% 98% 3% —% 3% 69% 75%
EMEA 5 7 5 38 55 4 9 5 47 65
Asia Pacific 5 2 18 57 82 4 3 17 56 80
Latin America 6 — 1 30 37 6 — 2 32 40
Total 4% 3% 7% 61% 75% 4% 3% 6% 56% 69%

1. Portfolio & Other primarily reflects sales related to the Merger (impacts all segments, except Performance Materials & Coatings and Industrial Intermediates & Infrastructure). Portfolio & Other also reflects the following divestitures: a portion of Dow AgroSciences' Brazil corn seed business ("DAS Divested Ag Business"), divested on November 30, 2017 (impacting Agriculture), global Ethylene Acrylic Acid copolymers and ionomers business ("EAA Business"), divested on September 1, 2017 (impacting Packaging & Specialty Plastics) and SKC Haas Display Films group of companies, divested June 30, 2017 (impacting Electronics & Imaging).

The Company reported net sales in the second quarter of 2018 of $24.2 billion, up 75 percent from $13.8 billion in the second quarter of 2017, primarily reflecting the Merger, demand growth and increased selling prices. Sales growth was broad-based with increases in all segments and geographic regions. Portfolio & Other changes contributed 61 percent of the sales increase, primarily reflecting the Merger, and impacted all segments, except Performance Materials & Coatings and Industrial Intermediates & Infrastructure. Volume increased 7 percent with gains in all segments, except Nutrition & Biosciences, which was flat. The most notable volume increases were in Industrial Intermediates & Infrastructure (up 18 percent), Packaging & Specialty Plastics (up 8 percent), Transportation & Advanced Polymers (up 6 percent) and Electronics & Imaging (up 5 percent). Volume increased in all geographic regions, including a double-digit increase in Asia Pacific (up 18 percent). Local price was up 4 percent compared with the same period last year, in response to higher feedstock and raw material costs. Local price increased in all geographic regions and most segments, with the most notable changes in Performance Materials & Coatings (up 10 percent) and Industrial Intermediates & Infrastructure (up 8 percent), which were partially offset by Electronics & Imaging (down 1 percent). Local price in Agriculture and Transportation & Advanced Polymers was flat. Currency was up 3 percent compared with the same period last year, driven primarily by EMEA (up 7 percent).

Net sales for the first six months of 2018 were $45.8 billion, up 69 percent from $27.1 billion in the same period last year, reflecting the Merger, higher sales volume, increased selling prices and the favorable impact of currency. Sales growth was broad-based with increases in all segments and geographic regions. Portfolio & Other changes contributed 56 percent of the sales increase, primarily reflecting the Merger. Volume increased 6 percent compared with the same period last year, as increases in Industrial Intermediates & Infrastructure (up 16 percent), Packaging & Specialty Plastics (up 9 percent), Nutrition & Biosciences (up 4 percent) and Electronics & Imaging and Transportation & Advanced Polymers (both up 3 percent) more than offset declines in Agriculture (down 3 percent) and Performance Materials & Coatings (down 1 percent). Safety & Construction volume was flat.

Volume increased in all geographic regions, including a double-digit increase in Asia Pacific (up 17 percent). Local price was up 4 percent compared with the same period last year, with increases in all geographic regions, driven by pricing initiatives in response to higher feedstock and raw material costs. Local price increased in most segments, with the most notable increases in Industrial Intermediates & Infrastructure and Performance Materials & Coatings (both up 10 percent). Local price in Agriculture, Electronics & Imaging and Transportation & Advanced Polymers was flat. Currency was up 3 percent compared with the same period last year, driven primarily by EMEA (up 9 percent).

As Reported Net Sales in the Current Period Compared with Pro Forma Net Sales in the Prior Period

Sales Variances by Segment and Geographic Region - Net Sales in Current Period Compared with Pro Forma Net Sales in Prior Period

Percentage change from prior year Three Months Ended Jun 30, 2018 Local Price & Product Mix Currency Volume Portfolio & Other 1 Total Six Months Ended Jun 30, 2018 Local Price & Product Mix Currency Volume Portfolio & Other 1 Total
Agriculture 4% 1% 20% —% 25% 2% 2% (5)% —% (1)%
Performance Materials & Coatings 10 3 2 — 15 10 4 — — 14
Industrial Intermediates & Infrastructure 8 3 18 — 29 10 4 16 — 30
Packaging & Specialty Plastics 1 3 8 — 12 1 3 8 — 12
Electronics & Imaging — 1 3 (5) (1) — 2 2 (5) (1)
Nutrition & Biosciences 1 3 4 11 19 1 4 4 11 20
Transportation & Advanced Polymers 5 3 6 — 14 5 4 5 — 14
Safety & Construction 1 2 3 — 6 1 3 3 — 7
Total 4% 2% 10% 1% 17% 3% 3% 4% 1% 11%
U.S. & Canada 4% —% 13% —% 17% 3% —% 1% —% 4%
EMEA 4 7 6 1 18 4 10 4 1 19
Asia Pacific 3 2 15 — 20 3 3 13 — 19
Latin America 5 (1) 1 1 6 5 (1) (1) 1 4
Total 4% 2% 10% 1% 17% 3% 3% 4% 1% 11%

1. Pro forma net sales for Agriculture excludes sales related to the November 30, 2017, divestiture of the DAS Divested Ag Business for the period January 1, 2017 through June 30, 2017. Pro forma net sales for Packaging & Specialty Plastics excludes sales related to the September 1, 2017, divestiture of the EAA Business for the period January 1, 2017 through June 30, 2017. Portfolio & Other includes sales for the acquisition of FMC Corporation's ("FMC") Health and Nutrition Business (the "H&N Business") acquired on November 1, 2017, impacting Nutrition & Biosciences. Portfolio & Other also reflects the following divestitures: SKC Haas Display Films group of companies (divested June 30, 2017) and the authentication business (divested on January 6, 2017), both impacting Electronics & Imaging; and, the divestiture of the global food safety diagnostic business (divested February 28, 2017), impacting Nutrition & Biosciences.

The Company reported net sales in the second quarter of 2018 of $24.2 billion, up 17 percent from pro forma net sales of $20.7 billion in the second quarter of 2017, with increases across all geographic regions and segments, except Electronics & Imaging (down 1 percent). Double-digit net sales increases were reported in Industrial Intermediates & Infrastructure (up 29 percent), Agriculture (up 25 percent), Nutrition & Biosciences (up 19 percent), Performance Materials & Coatings (up 15 percent), Transportation & Advanced Polymers (up 14 percent) and Packaging & Specialty Plastics (up 12 percent). Volume increased 10 percent compared with pro forma results in the same period last year, with gains in all geographic regions and segments, including double-digit increases in Agriculture (up 20 percent), Industrial Intermediates & Infrastructure (up 18 percent), Asia Pacific (up 15 percent) and U.S. & Canada (up 13 percent). Local price was up 4 percent compared with pro forma results in the same period last year with increases in all geographic regions, in response to higher feedstock and raw material costs. Local price increased across most segments, including a double-digit increase in Performance Materials & Coatings (up 10 percent). Local price in Electronics & Imaging was flat. Currency was up 2 percent compared with the same period last year, driven primarily by EMEA (up 7 percent).

Net sales for the first six months of 2018 were $45.8 billion, up 11 percent from pro forma net sales of $41.2 billion in the same period last year, with increases across most segments and all geographic regions. Double-digit net sales increases were reported in Industrial Intermediates & Infrastructure (up 30 percent), Nutrition & Biosciences (up 20 percent), Performance Materials & Coatings and Transportation & Advanced Polymers (both up 14 percent) and Packaging & Specialty Plastics (up 12 percent). These increases were partially offset by declines in Agriculture and Electronics & Imaging (both down 1 percent). Net sales increased in EMEA and Asia Pacific (both up 19 percent) and U.S. & Canada and Latin America (both up 4 percent). Volume increased 4 percent compared with pro forma results in the same period last year, as increases in Industrial Intermediates & Infrastructure (up 16 percent), Packaging & Specialty Plastics (up 8 percent), Transportation & Advanced Polymers (up 5 percent), Nutrition & Biosciences (up 4 percent), Safety & Construction (up 3 percent) and Electronics & Imaging (up 2 percent) more than offset a decline in Agriculture (down 5 percent). Performance Materials & Coatings volume was flat. Volume increased in all geographic regions, except for Latin America (down 1 percent), including a double-digit increase in Asia Pacific (up 13 percent). Local price was up 3 percent compared with pro forma results in the same period last year with increases in all geographic regions, driven by pricing initiatives in response to higher feedstock and raw material costs. Local price increased across most segments, including double-digit increases in Industrial Intermediates & Infrastructure and Performance Materials & Coatings (both up 10 percent). Local price in Electronics & Imaging was flat. Currency was up 3 percent compared with the same period last year, driven primarily by EMEA (up 10 percent).

Cost of Sales

COS was $18.0 billion in the second quarter of 2018, up from $10.8 billion in the second quarter of 2017. The increase was primarily due to the Merger, increased sales volume, higher feedstock and other raw material costs, and higher planned maintenance turnaround costs, which more than offset lower commissioning expenses related to U.S. Gulf Coast growth projects and cost synergies. COS in the second quarter of 2018 was also negatively impacted by a $682 million charge for the fair value step-up in DuPont's inventories as result of the Merger and the acquisition of the H&N Business, related to Agriculture ($676 million), Nutrition & Biosciences ($4 million) and Packaging & Specialty Plastics ($2 million).

For the first six months of 2018, COS was $34.3 billion, up from $21.0 billion in the first six months of 2017. The increase was primarily due to the Merger, higher sales volume, higher feedstock and other raw material costs, increased costs from planned maintenance turnaround activity and unplanned events, which more than offset lower commissioning expenses related to U.S. Gulf Coast growth projects and cost synergies. COS in the first six months of 2018 was negatively impacted by a $1,385 million charge for the fair value step-up in DuPont's inventories as a result of the Merger and the acquisition of the H&N Business, related to Agriculture ($1,315 million), Nutrition & Biosciences ($67 million), Packaging & Specialty Plastics ($2 million) and Safety & Construction ($1 million).

Research and Development Expenses

R&D expenses totaled $803 million in the second quarter of 2018, up from $408 million in the second quarter of 2017. For the first six months of 2018, R&D expenses totaled $1,571 million, up from $827 million in the first six months of 2017. R&D expenses increased primarily due to the Merger.

Selling, General and Administrative Expenses

SG&A expenses were $1,933 million in the second quarter of 2018, up from $720 million in the second quarter of 2017. For the first six months of 2018, SG&A expenses totaled $3,647 million, up from $1,479 million in the first six months of 2017. SG&A expenses increased primarily due to the Merger.

Amortization of Intangibles

Amortization of intangibles was $488 million in the second quarter of 2018, up from $157 million in the second quarter of 2017. In the first six months of 2018, amortization of intangibles was $962 million, up from $312 million in the same period last year. The increase in amortization is primarily due to an increase in intangible assets as a result of the Merger. See Note 10 to the Consolidated Financial Statements for additional information on intangible assets.

Restructuring and Asset Related Charges (Credits) - Net

DowDuPont Cost Synergy Program

In September and November 2017, DowDuPont approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the “Synergy Program”), adopted by the DowDuPont Board of Directors. The plan is designed to integrate and optimize the organization following the Merger and in preparation for the Intended Business Separations. Based on all actions approved to date under the Synergy Program, the Company expects to record total pretax restructuring charges of approximately $2 billion, comprised of approximately $845 million to $935 million of severance and related benefit costs; $400 million to $540 million of asset write-downs and write-offs; and $400 million to $450 million of costs associated with exit and disposal activities. The Synergy Program includes certain asset actions that are reflected in the preliminary fair value measurement of DuPont’s assets as of the Merger date. Current estimated total pretax restructuring charges could be impacted by future adjustments to the preliminary fair value of DuPont’s assets.

For the three months ended June 30, 2018, the Company recorded pretax restructuring charges of $182 million, consisting of severance and related benefit costs of $122 million, asset write-downs and write-offs of $33 million and costs associated with exit and disposal activities of $27 million. For the six months ended June 30, 2018, the Company recorded pretax restructuring charges of $442 million, consisting of severance and related benefit costs of $294 million, asset write-downs and write-offs of $81 million and costs associated with exit and disposal activities of $67 million. The restructuring charges by segment were as follows: $95 million in Agriculture, $19 million in Safety & Construction, $11 million in Industrial Intermediates & Infrastructure, $3 million in Packaging & Specialty Plastics, $2 million in Electronics & Imaging, $313 million in Corporate and a benefit of

$1 million in Transportation & Advanced Polymers. The Company expects to record additional restructuring charges in 2018 and 2019 and expects the Synergy Program to be completed by the end of 2019.

Dow 2016 Restructuring Plan

For the three months ended June 30, 2018, Dow recorded pretax restructuring charges of $7 million, consisting of a favorable adjustment to the severance reserve of $8 million and a charge of $15 million for costs associated with exit and disposal activities. For the six months ended June 30, 2018, Dow recorded pretax restructuring charges of $6 million, consisting of a favorable adjustment to the severance reserve of $8 million (related to Corporate) and a charge of $14 million (related to Performance Materials & Coatings) for costs associated with exit and disposal activities. See Note 5 to the Consolidated Financial Statements for details on the Company's restructuring activities.

Integration and Separation Costs

Integration and separation costs, which reflect costs related to the Merger and the ownership restructure of Dow Silicones, as well as post-Merger integration and Intended Business Separation activities, were $558 million in the second quarter of 2018, up from $136 million in the second quarter of 2017. In the first six months of 2018, integration and separation costs were $1,015 million, up from $245 million in the same period last year. Integration and separation costs are related to the Corporate segment.

Equity in Earnings of Nonconsolidated Affiliates

The Company's share of the earnings of nonconsolidated affiliates was $250 million in the second quarter of 2018, up from $54 million in the second quarter of 2017, primarily due to higher earnings from the Kuwait joint ventures (driven by increased volume and improved monoethylene glycol prices) and lower equity losses from Sadara.

In the first six months of 2018, the Company's share of the earnings of nonconsolidated affiliates was $507 million, up from $250 million in the first six months of 2017, as lower equity losses from Sadara and higher earnings from the Kuwait joint ventures were partially offset by lower equity earnings from the HSC Group, which reflected customer settlements in the first quarter of 2017 related to long-term polysilicon sales agreements.

Sundry Income (Expense) - Net

Sundry income (expense) – net includes a variety of income and expense items such as foreign currency exchange gains or losses, interest income, dividends from investments, gains and losses on sales of investments and assets, non-operating pension and other postretirement benefit plan credits or costs, and certain litigation matters. Sundry income (expense) – net in the second quarter of 2018 was income of $178 million, compared with income of $322 million in the second quarter of 2017. The second quarter of 2018 included income related to non-operating pension and other postretirement benefit plans, interest income, and gains on sales of investments and other assets, including a $24 million gain related to Agriculture asset sales. These gains more than offset foreign currency exchange losses and a $41 million loss for an adjustment related to the Dow Silicones ownership restructure (related to Performance Materials & Coatings). The second quarter of 2017 included a $137 million gain related to the Nova patent infringement award (related to Packaging & Specialty Plastics) and gains on the sale of assets and investments.

In the first six months of 2018, sundry income (expense) - net was income of $293 million compared with expense of $122 million in the first six months of 2017. In addition to the amounts previously discussed, the first six months of 2018 included a $20 million gain for post-closing adjustments on Dow's sale of its equity interest in MEGlobal (related to Industrial Intermediates & Infrastructure) and a $50 million foreign exchange loss related to adjustments to foreign currency exchange contracts for the change in the U.S. tax rate (related to Corporate). The first six months of 2017 included a $469 million loss related to the Dow Agroscience arbitration matter with Bayer CropScience (reflected in Agriculture). See Notes 1, 2, 6, 13 and 16 to the Consolidated Financial Statements for additional information.

Interest Expense and Amortization of Debt Discount

Interest expense and amortization of debt discount was $360 million in the second quarter of 2018, up from $226 million in the second quarter of 2017. Interest expense and amortization of debt discount was $710 million for the first six months of 2018, up from $445 million in the same period last year. The increase was primarily related to debt assumed in the Merger.

Provision for Income Taxes on Continuing Operations

The Company's effective tax rate fluctuates based on, among other factors, where income is earned, reinvestment assertions regarding foreign income and the level of income relative to tax credits available. The Company's tax rate is also influenced by the level of equity earnings, since most of the earnings from the Company's equity method investments are taxed at the joint venture level.

On December 22, 2017, the Tax Cuts and Jobs Act ("The Act") was enacted. The Act reduces the U.S. federal corporate income tax rate from 35 percent to 21 percent, requires companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously deferred, creates new provisions related to foreign sourced earnings, eliminates the domestic manufacturing deduction and moves towards a territorial system. The Company recorded adjustments related to The Act in the first and second quarters of 2018 which resulted in charges of $71 million and $7 million, respectively, to "Provision for income taxes on continuing operations."

The effective tax rate for the second quarter of 2018 was 23.9 percent, compared with an effective tax rate of 25.1 percent for the second quarter of 2017. The tax rate in the second quarter of 2018 was favorably impacted by the reduced U.S. federal corporate tax rate. The tax rate for the second quarter of 2017 was primarily impacted by the geographic mix of earnings.

For the first six months of 2018, the effective tax rate was 24.4 percent, compared with 22.7 percent for the first six months of 2017. The tax rate for the first six months of 2018 was unfavorably impacted by non-deductible amortization of the fair value step-up in DuPont’s inventories as a result of the Merger, along with certain provisions in The Act related to the taxability of foreign earnings. The tax rate was favorably impacted by the reduced U.S. federal corporate tax rate and the tax benefits related to the issuance of stock-based compensation. In addition to the favorable effective tax rate impact of the geographic mix of earnings, the tax rate for the first six months of 2017 reflected the tax benefit from the Bayer CropScience arbitration matter and the adoption of Accounting Standards Update ("ASU") 2016-09, which resulted in the recognition of excess tax benefits related to equity compensation in the provision for income taxes. See Notes 7 and 13 to the Consolidated Financial Statements for additional information.

Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests was $35 million in the second quarter of 2018, down from $38 million in the second quarter of 2017. For the first six months of 2018, net income attributable to noncontrolling interests was $79 million, compared with $65 million for the same period last year.

Net Income Available for DowDuPont Inc. Common Stockholders

Net income available for common stockholders was $1,768 million, or $0.76 per share, in the second quarter of 2018, compared with $1,321 million, or $1.07 per share, in the second quarter of 2017. Net income available for common stockholders in the first six months of 2018 was $2,872 million or $1.23 per share, compared with $2,209 million, or $1.79 per share, in the same period of 2017. See Note 8 to the Consolidated Financial Statements for details on the Company's earnings per share calculations.

SUPPLEMENTAL UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION

The following supplemental unaudited pro forma combined statements of income (the "unaudited pro forma income statements") for DowDuPont are presented to illustrate the estimated effects of the Merger, assuming that the Merger had been consummated on January 1, 2016. Activity for the three and six months ended June 30, 2017, was prepared on a pro forma basis (the “unaudited pro forma information”). The unaudited pro forma information was prepared in accordance with Article 11 of Regulation S-X. Pro forma adjustments have been made for (1) the preliminary purchase accounting impact, (2) accounting policy alignment, (3) the elimination of the effect of events that are directly attributable to the Merger Agreement (e.g., one-time transaction costs), (4) the elimination of the impact of transactions between Dow and DuPont, and (5) the elimination of the effect of consummated divestitures required as a condition of approval for the Merger. Events that are not expected to have a continuing impact on the combined results (e.g., inventory step-up costs) are excluded from the unaudited pro forma information. The unaudited pro forma information does not reflect restructuring or integration activities or other costs following the Merger that may be incurred to achieve cost or growth synergies of DowDuPont. The unaudited pro forma income statement provides shareholders with summary financial information and historical data that is on a basis consistent with how DowDuPont reports current financial information.

The Merger was accounted for under Accounting Standards Codification ("ASC") Topic 805, "Business Combinations" ("ASC 805"), under which Dow was designated as the accounting acquirer in the Merger for accounting purposes. Under ASC 805, Dow accounted for the transaction by using Dow historical financial information and accounting policies and adding the assets and liabilities of DuPont as of August 31, 2017 (the "Merger Date") at their respective fair values. The assets and liabilities of DuPont were measured based on various preliminary estimates at the Merger Date using assumptions that DowDuPont believes are reasonable based on information that was currently available. The fair value estimates reflected in the unaudited pro forma information are based on those used in the Current Report on Form 8-K/A filed with the SEC on October 26, 2017, and subsequent measurement period adjustments are not reflected. DowDuPont intends to complete and finalize the allocation of consideration as soon as practicable within the measurement period in accordance with ASC 805, but no later than one year following the closing date of the Merger. Differences between these preliminary estimates and the final acquisition accounting may occur and these differences could have a material impact on the accompanying unaudited pro forma income statements and DowDuPont’s future results of operations.

The unaudited pro forma income statements have been presented for informational purposes only and are not necessarily indicative of what DowDuPont’s results of operations actually would have been had the Merger been completed on January 1, 2016. In addition, the unaudited pro forma income statements do not purport to project the future operating results of the Company. The unaudited pro forma income statements were based on and should be read in conjunction with the separate historical financial statements and accompanying notes contained in each of the Dow and DuPont Quarterly Reports on Form 10-Q for the quarter ended June 30, 2017. See Notes 1 and 3 to the Consolidated Financial Statements for additional information.

Unaudited Pro Forma Combined Statement of Income

Three Months Ended Jun 30, 2017

In millions, except per share amounts

Adjustments Historical Dow 1, 3 Historical DuPont 1, 3 Reclass 2, 3 Divestitures 4 Pro Forma 5 Pro Forma
Net sales $13,834 $7,424 $28 $(510) $(59) $20,717
Cost of sales 10,761 4,134 138 (218) 61 14,876
Other operating charges — 176 (176) — — —
Research and development expenses 408 426 (10) (43) 7 788
Selling, general and administrative expenses 856 1,317 (361) (53) 11 1,770
Other (loss) income, net — (125) 125 — — —
Amortization of intangibles 157 — 57 — 221 435
Restructuring and asset related charges (credits) - net (12) 160 — — — 148
Integration and separation costs — — 352 (15) (41) 296
Equity in earnings of nonconsolidated affiliates 54 — 24 — (5) 73
Sundry income (expense) - net 300 — (150) (9) — 141
Interest income 22 — (22) — — —
Interest expense and amortization of debt discount 226 99 — — (30) 295
Income from continuing operations before income taxes 1,814 987 5 (190) (293) 2,323
Provision for income taxes on continuing operations 455 128 5 (46) (102) 440
Income from continuing operations, net of tax 1,359 859 — (144) (191) 1,883
Net income attributable to noncontrolling interests 38 7 — — 3 48
Net income from continuing operations attributable to DowDuPont Inc. 1,321 852 — (144) (194) 1,835
Preferred stock dividends — 3 — — (3) —
Net income from continuing operations available for DowDuPont Inc. common stockholders $1,321 $849 $— $(144) $(191) $1,835
Per common share data:
Earnings per common share from continuing operations - basic $0.79
Earnings per common share from continuing operations - diluted $0.78
Weighted-average common shares outstanding - basic 2,325.0
Weighted-average common shares outstanding - diluted 2,347.7

1. Reflects historical consolidated statements of income included in Dow's and DuPont's Quarterly Reports on Form 10-Q for the quarter ended June 30, 2017.

2. Certain reclassifications were made to conform with the presentation used for DowDuPont. The reclassifications are consistent with those identified and disclosed in the Current Report on Form 8-K/A filed with the SEC on October 26, 2017.

3. Amounts have been updated to reflect certain reclassifications required under ASU 2017-07, "Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost," which was adopted on January 1, 2018, and required retrospective application.

4. Includes the following divestitures agreed to with certain regulatory agencies as a condition of approval for the Merger: Dow’s EAA Business; the DAS Divested Ag Business; and DuPont’s cereal broadleaf herbicides and chewing insecticides portfolio as well as its crop protection research and development pipeline and organization. For additional information regarding these divestitures, see Note 4 to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.

5. Certain pro forma adjustments were made to illustrate the estimated effects of the Merger, assuming that the Merger had been consummated on January 1, 2016. The pro forma adjustments are consistent with those identified and disclosed in the Company's Current Report on Form 8-K/A filed with the SEC on October 26, 2017.

Unaudited Pro Forma Combined Statement of Income

Six Months Ended Jun 30, 2017

In millions, except per share amounts

Adjustments Historical Dow 1, 3 Historical DuPont 1, 3 Reclass 2, 3 Divestitures 4 Pro Forma 5 Pro Forma
Net sales $27,064 $15,167 $73 $(994) $(126) $41,184
Cost of sales 20,955 8,448 271 (417) 52 29,309
Other operating charges — 380 (380) — — —
Research and development expenses 827 826 (20) (78) 14 1,569
Selling, general and administrative expenses 1,724 2,546 (610) (102) 22 3,580
Other (loss) income, net — 77 (77) — — —
Amortization of intangibles 312 — 108 — 443 863
Restructuring and asset related charges (credits) - net (13) 312 — — — 299
Integration and separation costs — — 631 (15) (78) 538
Equity in earnings of nonconsolidated affiliates 250 — 42 — (11) 281
Sundry income (expense) - net (169) — (26) (11) — (206)
Interest income 47 — (47) — — —
Interest expense and amortization of debt discount 445 183 — — (60) 568
Income from continuing operations before income taxes 2,942 2,549 (35) (393) (530) 4,533
Provision for income taxes on continuing operations 668 352 (35) (78) (186) 721
Income from continuing operations, net of tax 2,274 2,197 — (315) (344) 3,812
Net income attributable to noncontrolling interests 65 15 — — 5 85
Net income from continuing operations attributable to DowDuPont Inc. 2,209 2,182 — (315) (349) 3,727
Preferred stock dividends — 5 — — (5) —
Net income from continuing operations available for DowDuPont Inc. common stockholders $2,209 $2,177 $— $(315) $(344) $3,727
Per common share data:
Earnings per common share from continuing operations - basic $1.60
Earnings per common share from continuing operations - diluted $1.59
Weighted-average common shares outstanding - basic 2,320.4
Weighted-average common shares outstanding - diluted 2,344.4

1. Reflects historical consolidated statements of income included in Dow's and DuPont's Quarterly Reports on Form 10-Q for the quarter ended June 30, 2017.

2. Certain reclassifications were made to conform with the presentation used for DowDuPont. The reclassifications are consistent with those identified and disclosed in the Current Report on Form 8-K/A filed with the SEC on October 26, 2017.

3. Amounts have been updated to reflect certain reclassifications required under ASU 2017-07, "Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost," which was adopted on January 1, 2018, and required retrospective application.

4. Includes the following divestitures agreed to with certain regulatory agencies as a condition of approval for the Merger: Dow’s EAA Business; the DAS Divested Ag Business; and DuPont’s cereal broadleaf herbicides and chewing insecticides portfolio as well as its crop protection research and development pipeline and organization. For additional information regarding these divestitures, see Note 4 to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.

5. Certain pro forma adjustments were made to illustrate the estimated effects of the Merger, assuming that the Merger had been consummated on January 1, 2016. The pro forma adjustments are consistent with those identified and disclosed in the Company's Current Report on Form 8-K/A filed with the SEC on October 26, 2017.

OUTLOOK

Broad-based consumer strength continues to drive economic expansion and DowDuPont's underlying business growth. Leading indicators, such as manufacturing output, employment, wages and consumer spending remain largely constructive, supporting increased global economic activity. The Company sees some discrete headwinds, most notably currency fluctuations, particularly in Agriculture, and higher raw materials costs in all three divisions. Looking ahead, DowDuPont continues to expect above-market growth through much of the Company's business portfolio, driven by its innovations, growth investments, geographic reach and leading market positions.

Impact From Recently Enacted Tariffs

Certain countries where the Company’s products are manufactured, distributed or sold have recently enacted or are considering imposing new tariffs on certain products. The Company has analyzed the potential impact from tariffs that took effect on July 6, 2018 and does not expect such tariffs will have a material impact on its results of operations in 2018 because of the Company’s mitigation actions and its global asset base. The Company will continue to monitor the situation and take actions, where possible, to mitigate any potential impact as events unfold.

SEGMENT RESULTS

The Company's measure of profit/loss for segment reporting purposes is Operating EBITDA (for the three and six months ended June 30, 2018) and pro forma Operating EBITDA (for the three and six months ended June 30, 2017) as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines Operating EBITDA as earnings (i.e., “Income from continuing operations before income taxes") before interest, depreciation, amortization and foreign exchange gains (losses), excluding the impact of significant items. Pro forma Operating EBITDA is defined as pro forma earnings (i.e., pro forma “Income from continuing operations before income taxes") before interest, depreciation, amortization and foreign exchange gains (losses), excluding the impact of adjusted significant items. Reconciliations of these measures can be found in Note 21 to the Consolidated Financial Statements. The Company also presents pro forma net sales for the three and six months ended June 30, 2017, as it is included in management’s measure of segment performance and is regularly reviewed by the CODM. Prior year data has been updated to conform with the current year presentation.

Pro forma adjustments used in the calculation of pro forma net sales and pro forma Operating EBITDA were determined in accordance with Article 11 of Regulation S-X and were based on the historical consolidated financial statements of Dow and DuPont, adjusted to give effect to the Merger as if it had been consummated on January 1, 2016. For additional information on the pro forma adjustments made, see Supplemental Unaudited Pro Forma Combined Financial Information in the preceding section.

AGRICULTURE

The Agriculture segment leverages the Company’s technology, customer relationships and industry knowledge to improve the quantity, quality and safety of the global food supply and the global production agriculture industry. Land available for worldwide agricultural production is increasingly limited so production growth will need to be achieved principally through improving crop yields and productivity. The segment’s two global businesses, Seed and Crop Protection, deliver a broad portfolio of products and services that are specifically targeted to achieve gains in crop yields and productivity, including well-established brands of seed products, crop chemicals, seed treatment, agronomy and digital services. R&D focuses on leveraging germplasm and plant science technology to increase farmer productivity and to enhance the value of grains and oilseeds through improved seed traits, superior seed germplasm and effective use of crop protection solutions.

In millions

Agriculture Three Months Ended Jun 30, 2018 Jun 30, 2017 Six Months Ended Jun 30, 2018 Jun 30, 2017
Net sales $5,730 $1,629 $9,538 $3,197
Pro forma net sales $4,595 $9,644
Operating EBITDA $1,685 $2,576
Pro forma Operating EBITDA $1,165 $2,626
Equity earnings $3 $2 $2 $4
Agriculture Percentage change from prior year Change in Net Sales from Prior Period due to: Three Months Ended Jun 30, 2018 Six Months Ended Jun 30, 2018
Local price & product mix —% —%
Currency 2 3
Volume 2 (3)
Portfolio & other 248 198
Total 252% 198%
Change in Net Sales in Current Period from Pro Forma Net Sales in Prior Period due to:
Local price & product mix 4% 2%
Currency 1 2
Volume 20 (5)
Portfolio & other — —
Total 25% (1)%

Agriculture net sales were $5,730 million in the second quarter of 2018, up from $1,629 million in the second quarter of 2017. Net sales in the second quarter of 2018 were up 25 percent from pro forma net sales of $4,595 million in the second quarter of 2017. The increase was primarily due to 20 percent in volume growth, a 4 percent increase in local price and a 1 percent benefit from currency.

Volume growth in the segment primarily reflected sales recovered from weather-related delays to the start of the planting seasons in the Northern Hemisphere, which benefited both Seed and Crop Protection, and growth in global insecticide sales driven by strong demand creation efforts for SPINOSYN™ products and new product launches, partially offset by lower expected planted area in U.S. & Canada for corn and soybeans. The increase in local price was driven by Seed from continued penetration of new corn hybrids and A-series soybeans.

Operating EBITDA was $1,685 million in the second quarter of 2018, up 45 percent from pro forma Operating EBITDA of $1,165 million in the second quarter of 2017. Volume growth, higher selling prices in Seed, cost synergies, favorable currency and lower pension/OPEB costs were partially offset by lower expected planted area in U.S. & Canada, higher soybean royalty costs, increased R&D spend to continue advancing the pipeline and investments in digital platforms.

Agriculture net sales were $9,538 million for the first six months of 2018, up from $3,197 million in the first six months of 2017. Net sales in the first six months of 2018 were down 1 percent from pro forma net sales of $9,644 million in the first six months of 2017. Net sales declined as a 5 percent decrease in volume was partially offset by a 2 percent increase in local price and a 2 percent benefit from currency.

The decline in volume was driven by lower expected planted area in U.S. & Canada and lower sales in the Brazil safrinha season, partially offset by growth in global insecticide sales driven by new product launches. The increase in local price was driven by Seed from continued penetration of new corn hybrids and A-series soybeans.

Operating EBITDA was $2,576 million in the first six months of 2018, down 2 percent from pro forma Operating EBITDA of $2,626 million in the first six months of 2017. Cost synergies, favorable currency, lower pension/OPEB costs and sales gains in Crop Protection were more than offset by higher soybean royalty costs, the weak safrinha season in Brazil, and investments to support new product launches and digital platforms.

Updated Outlook

The Operating EBTIDA outlook for 2018 is now expected to be up slightly as compared with 2017 pro forma Operating EBITDA driven by favorable impacts on net sales from new product introductions and pricing, as well as favorable impacts from cost synergies and lower pension/OPEB costs, partly offset by lower expected planted area in U.S. & Canada, a weaker safrinha season, higher royalty expense and investments in R&D and digital platforms.

PERFORMANCE MATERIALS & COATINGS

The Performance Materials & Coatings segment consists of two global businesses: Coatings & Performance Monomers and Consumer Solutions. Using silicones, acrylics and cellulosics-based technology platforms, these businesses serve the needs of the coatings, home care, personal care, appliance and industrial end-markets. The segment has broad geographic reach with R&D and manufacturing facilities located in key geographic regions. This segment also includes the results of the HSC Group joint ventures.

In preparation for the Intended Business Separations, effective July 1, 2018, the results of the HSC Group joint ventures will be realigned from Performance Materials & Coatings to Electronics & Imaging. The information below does not reflect this realignment.

In millions

Performance Materials & Coatings Three Months Ended Jun 30, 2018 Jun 30, 2017 Six Months Ended Jun 30, 2018 Jun 30, 2017
Net sales $2,599 $2,273 $4,903 $4,352
Pro forma net sales $2,255 $4,318
Operating EBITDA $569 $1,197
Pro forma Operating EBITDA $540 $1,021
Equity earnings $36 $41 $77 $132
Performance Materials & Coatings Percentage change from prior year Change in Net Sales from Prior Period due to: Three Months Ended Jun 30, 2018 Six Months Ended Jun 30, 2018
Local price & product mix 10% 10%
Currency 3 3
Volume 1 (1)
Portfolio & other — 1
Total 14% 13%
Change in Net Sales in Current Period from Pro Forma Net Sales in Prior Period due to:
Local price & product mix 10% 10%
Currency 3 4
Volume 2 —
Portfolio & other — —
Total 15% 14%

Performance Materials & Coatings net sales were $2,599 million in the second quarter of 2018, up from net sales of $2,273 million in the second quarter of 2017. Net sales increased 15 percent compared with pro forma net sales of $2,255 million in the same quarter last year, with local price up 10 percent, a benefit from currency of 3 percent, primarily in EMEA, and volume up 2 percent. Local price increased in all geographic regions and in both businesses. Local price increased in Consumer Solutions primarily due to disciplined price/volume management in upstream silicone intermediates, as well as in performance silicone products.

Coatings & Performance Monomers local price increased in all geographic regions in response to higher feedstock and raw material costs. Volume increased in Coatings & Performance Monomers driven by demand growth in architectural coatings. Volume increased in Consumer Solutions due to broad-based demand in Asia Pacific, while volume decreased in all other geographic regions, except U.S. & Canada, which was flat.

Operating EBITDA was $569 million in the second quarter of 2018, up 5 percent from pro forma Operating EBITDA of $540 million in the second quarter of 2017, as higher selling prices more than offset increased feedstock and other raw material costs and lower gains from sales of assets and investments.

Performance Materials & Coatings net sales for the first six months of 2018 were $4,903 million, up from net sales of $4,352 million in the first six months of 2017. Net sales increased 14 percent compared with pro forma net sales of $4,318 million in the first six months of 2017, with local price up 10 percent and a benefit from currency of 4 percent, primarily in EMEA, while volume was flat. Local price increased in both businesses and all geographic regions. Volume increased in Consumer Solutions and decreased in Coatings & Performance Monomers. Volume decreased in all geographic regions, except Asia Pacific.

Operating EBITDA was $1,197 million for the first six months of 2018, up 17 percent from pro forma Operating EBITDA of $1,021 million in the first six months of 2017, as higher selling prices and cost synergies more than offset increased feedstock and other raw material costs, lower gains from the sales of assets and investments, and lower equity earnings from the HSC Group, which reflected customer settlements in the first quarter of 2017 related to long-term polysilicon sales agreements.

Updated Outlook

The Operating EBITDA outlook for 2018 is expected to improve when compared with 2017 pro forma Operating EBITDA as anticipated declines in equity earnings from the HSC Group joint ventures, due to settlements with a customer related to long-term polysilicon sales agreements in 2017, will no longer have an unfavorable impact on the segment with the realignment from Performance Materials & Coatings to Electronics & Imaging.

INDUSTRIAL INTERMEDIATES & INFRASTRUCTURE

The Industrial Intermediates & Infrastructure segment consists of three global businesses: Construction Chemicals, Industrial Solutions, and Polyurethanes & CAV. These customer-centric global businesses develop and market customized materials using advanced technology and unique chemistries. These businesses serve the needs of market segments as diverse as appliance, coatings, infrastructure, and oil and gas. The segment has broad geographic reach and R&D and manufacturing facilities located in key geographic regions. This segment also includes a portion of the results of EQUATE Petrochemical Company K.S.C.C. ("EQUATE"), The Kuwait Olefins Company K.S.C.C. ("TKOC"), Map Ta Phut Olefins Company Limited and Sadara, all joint ventures of the Company.

Dow is responsible for marketing a majority of Sadara products outside of the Middle East zone through Dow's established sales channels. As part of this arrangement, Dow purchases and sells Sadara products for a marketing fee.

In millions

Industrial Intermediates & Infrastructure Three Months Ended Jun 30, 2018 Jun 30, 2017 Six Months Ended Jun 30, 2018 Jun 30, 2017
Net sales $3,885 $3,015 $7,600 $5,866
Pro forma net sales $3,013 $5,860
Operating EBITDA $682 $1,336
Pro forma Operating EBITDA $417 $929
Equity earnings (losses) $96 $(13) $245 $60
Industrial Intermediates & Infrastructure Percentage change from prior year Change in Net Sales from Prior Period due to: Three Months Ended Jun 30, 2018 Six Months Ended Jun 30, 2018
Local price & product mix 8% 10%
Currency 3 4
Volume 18 16
Portfolio & other — —
Total 29% 30%
Change in Net Sales in Current Period from Pro Forma Net Sales in Prior Period due to:
Local price & product mix 8% 10%
Currency 3 4
Volume 18 16
Portfolio & other — —
Total 29% 30%

Industrial Intermediates & Infrastructure net sales were $3,885 million in the second quarter of 2018, up from net sales of $3,015 million in the second quarter of 2017. Net sales increased 29 percent compared with pro forma net sales of $3,013 million in the same quarter last year, with volume up 18 percent, local price up 8 percent and currency up 3 percent. Volume and local price increased in all businesses and geographic regions. Polyurethanes & CAV reported volume increases in all geographic regions, reflecting growth in EMEA and Asia Pacific from the continued ramp up of production from Sadara and increased demand for vinyl chloride monomer ("VCM") and methylene diphenyl diisocyanate ("MDI") in North America. Industrial Solutions volume increased in all geographic regions reflecting increasing production from Sadara and increased demand in products sold in electronics processing, food and feed manufacturing, pharmaceutical applications and crop protection. Construction Chemicals volume increased driven by higher demand for acrylic and methyl cellulosics-based products in North America. Local price increases were driven by higher feedstock and other raw material costs, pricing initiatives and increased demand for caustic soda and products sold in downstream systems applications. Currency had a benefit of 3 percent, primarily in EMEA.

Operating EBITDA was $682 million in the second quarter of 2018, up 64 percent compared with pro forma Operating EBITDA of $417 million in the second quarter of 2017. Operating EBITDA increased as the impact of higher selling prices, demand growth, the benefit from currency on sales, cost synergies, higher equity earnings from the Kuwait joint ventures and lower equity losses from Sadara more than offset higher feedstock and other raw material costs and the unfavorable impact of currency on costs.

Industrial Intermediates & Infrastructure net sales for the first six months of 2018 were $7,600 million, up from net sales of $5,866 million in the first six months of 2017. Net sales increased 30 percent compared with pro forma net sales of $5,860 million in the first six months of 2017, with volume up 16 percent, local price up 10 percent and currency up 4 percent. Volume and local price increased in all businesses and geographic regions.

Operating EBITDA was $1,336 million for the first six months of 2018, up 44 percent from pro forma Operating EBITDA of $929 million in the first six months of 2017. Compared with pro forma Operating EBITDA from the same period last year, Operating EBITDA increased as the impact of higher selling prices, demand growth, the benefit from currency on sales, cost synergies, higher equity earnings from the Kuwait joint ventures and lower equity losses from Sadara more than offset higher feedstock and other raw material costs and the unfavorable impact of currency on costs.

PACKAGING & SPECIALTY PLASTICS

The Packaging & Specialty Plastics segment is a market-oriented portfolio composed of two global businesses: Hydrocarbons & Energy and Packaging and Specialty Plastics. The segment is advantaged through its low cost position into key feedstocks and broad geographic reach, with manufacturing facilities located in all geographic regions. It also benefits from R&D expertise to deliver leading-edge technology that provides a competitive benefit to customers in food packaging and other high-growth end-use markets like transportation and consumer durables. Taken together, the businesses in this segment represent the world's leading plastics franchise. This segment also includes the results of The Kuwait Styrene Company K.S.C.C. and The SCG-Dow Group, as well as a portion of the results of EQUATE, TKOC, Map Ta Phut Olefins Company Limited and Sadara, all joint ventures of the Company.

Dow is responsible for marketing a majority of Sadara products outside of the Middle East zone through Dow’s established sales channels. As part of this arrangement, Dow purchases and sells Sadara products for a marketing fee.

In millions

Packaging & Specialty Plastics Three Months Ended Jun 30, 2018 Jun 30, 2017 Six Months Ended Jun 30, 2018 Jun 30, 2017
Net sales $6,099 $5,079 $12,109 $10,104
Pro forma net sales $5,428 $10,810
Operating EBITDA $1,330 $2,631
Pro forma Operating EBITDA $1,163 $2,277
Equity earnings $108 $33 $167 $66
Packaging & Specialty Plastics Percentage change from prior year Change in Net Sales from Prior Period due to: Three Months Ended Jun 30, 2018 Six Months Ended Jun 30, 2018
Local price & product mix 2% 1%
Currency 3 3
Volume 8 9
Portfolio & other 7 7
Total 20% 20%
Change in Net Sales in Current Period from Pro Forma Net Sales in Prior Period due to:
Local price & product mix 1% 1%
Currency 3 3
Volume 8 8
Portfolio & other — —
Total 12% 12%

Packaging & Specialty Plastics net sales were $6,099 million in the second quarter of 2018, up from net sales of $5,079 million in the second quarter of 2017. Net sales increased 12 percent compared with pro forma net sales of $5,428 million in the same quarter last year, with volume up 8 percent, currency up 3 percent, primarily in EMEA, and local price up 1 percent. Volume increased in both businesses and across all geographic regions supported by new capacity additions on the U.S. Gulf Coast and increased production at Sadara. Packaging and Specialty Plastics volume growth was driven by double-digit increases in food and specialty packaging, industrial and consumer packaging solutions and rigid packaging applications. Volume also increased from strong demand growth in elastomers applications. Hydrocarbons & Energy volume increased due to higher sales of ethylene and ethylene by-products. Local price increased in all areas, except North America, which was flat. Local price increased in Packaging and Specialty Plastics in response to higher feedstock and other raw material costs while price was flat in Hydrocarbons & Energy.

Operating EBITDA was $1,330 million in the second quarter of 2018, up 14 percent from pro forma Operating EBITDA of $1,163 million in the second quarter of 2017. Compared with pro forma Operating EBITDA from the same quarter last year, Operating EBITDA increased as the impact of higher sales volume, the benefit from currency on sales, increased supply from growth projects, cost synergies, higher equity earnings and lower start-up and commissioning costs more than offset higher feedstock and other raw materials costs, the unfavorable impact of currency on costs and increased costs from planned maintenance turnarounds.

Packaging & Specialty Plastics net sales for the first six months of 2018 were $12,109 million, up from net sales of $10,104 million in the first six months of 2017. Net sales increased 12 percent compared with pro forma net sales of $10,810 million in the first six months of 2017, with volume up 8 percent, currency up 3 percent, primarily in EMEA, and local price up 1 percent. Volume increased in both businesses and across all geographic regions primarily due to new capacity additions on the U.S. Gulf Coast and increased production at Sadara. Local price increased in Packaging and Specialty Plastics in response to higher feedstock and other raw material costs which more than offset decreases in Hydrocarbons prices.

Operating EBITDA was $2,631 million for the first six months of 2018, up 16 percent from pro forma Operating EBITDA of $2,277 million in the first six months of 2017. Compared with pro forma Operating EBITDA from the same period last year, Operating EBITDA increased as the impact of higher sales volume, the benefit from currency on sales, increased supply from growth projects, cost synergies, higher equity earnings and lower start-up and commissioning costs more than offset higher feedstock and other raw materials costs, the unfavorable impact of currency on costs, increased costs from planned maintenance turnarounds and the impact of weather-related disruptions on the U.S. Gulf Coast.

ELECTRONICS & IMAGING

The Electronics & Imaging segment is a leading global supplier of differentiated materials and systems for a broad range of consumer electronics including mobile devices, television monitors, personal computers and electronics used in a variety of industries. The segment is a leading provider of materials and solutions for the fabrication of semiconductors and integrated circuits and also provides innovative metallization processes for metal finishing, decorative, and industrial applications. Electronics & Imaging is a leading global supplier of key materials for the manufacturing of photovoltaics ("PV") and solar cells, including innovative metallization pastes and back sheet materials for the production of solar cells and solar modules and in the advanced printing and packaging graphics industry providing flexographic printing inks, photopolymer plates, and platemaking systems used in digital printing applications for textile, commercial and home-office use. In addition, the segment provides cutting-edge materials for the manufacturing of rigid and flexible displays for liquid crystal displays ("LCD"), advanced-matrix organic light emitting diode ("AMOLED"), and quantum dot ("QD") applications.

In preparation for the Intended Business Separations, effective July 1, 2018, the results of the HSC Group joint ventures will be realigned from Performance Materials & Coatings to Electronics & Imaging. The information below does not reflect this realignment.

In millions

Electronics & Imaging Three Months Ended Jun 30, 2018 Jun 30, 2017 Six Months Ended Jun 30, 2018 Jun 30, 2017
Net sales $1,203 $677 $2,356 $1,332
Pro forma net sales $1,221 $2,385
Operating EBITDA $372 $729
Pro forma Operating EBITDA $410 $737
Equity earnings $6 $— $13 $—
Electronics & Imaging Percentage change from prior year Change in Net Sales from Prior Period due to: Three Months Ended Jun 30, 2018 Six Months Ended Jun 30, 2018
Local price & product mix (1)% —%
Currency 1 1
Volume 5 3
Portfolio & other 73 73
Total 78% 77%
Change in Net Sales in Current Period from Pro Forma Net Sales in Prior Period due to:
Local price & product mix —% —%
Currency 1 2
Volume 3 2
Portfolio & other (5) (5)
Total (1)% (1)%

Electronics & Imaging net sales were $1,203 million in the second quarter of 2018, up from $677 million in the second quarter of 2017. Net sales in the second quarter of 2018 were down 1 percent from pro forma net sales of $1,221 million in the second quarter of 2017. Net sales declined as a 5 percent unfavorable impact from portfolio actions related to the prior year divestiture of the SKC Haas Display Films business, was partially offset by volume growth of 3 percent and a 1 percent benefit from currency.

Volume growth in the segment was driven by gains in interconnect solutions and continued strength in semiconductor technologies, primarily in Asia Pacific. Continued demand for consumer electronics, as well as industrial applications, drove volume gains in interconnect solutions. Increased semiconductor content in end-use applications drove strong demand in both chemical mechanical planarization (“CMP”) and advanced packaging market segments. Partially offsetting this growth was a decline in photovoltaic & advanced materials on reduced demand for TEDLAR® film and SOLAMET® paste as module production slowed in the quarter resulting from revised incentive policies in China.

Operating EBITDA was $372 million in the second quarter of 2018, down 9 percent compared with pro forma Operating EBITDA of $410 million in the second quarter of 2017. Cost synergies, volume growth, lower pension/OPEB costs and favorable currency were more than offset by the absence of a prior-year gain on the sale of a business and higher unit costs.

Electronics & Imaging net sales were $2,356 million for the first six months of 2018, up from $1,332 million in the first six months of 2017. Net sales for the first six months of 2018 were down 1 percent from pro forma net sales of $2,385 million in the first six months of 2017. Net sales declined as a 5 percent unfavorable impact from portfolio actions related to prior year divestitures of the SKC Haas Display Films and Authentications businesses, was partially offset by volume growth of 2 percent and a 2 percent benefit from currency. Volume growth in the segment was driven by gains in semiconductor technologies and interconnect solutions, primarily in Asia Pacific, partially offset by a decline in photovoltaic & advanced materials.

Operating EBITDA was $729 million for the first six months of 2018, down 1 percent from pro forma Operating EBITDA of $737 million for the first six months of 2017. Cost synergies, lower pension/OPEB costs, volume growth and favorable currency, were more than offset by the absence of a prior-year gain on the sale of a business and higher unit costs.

Updated Outlook

The Operating EBITDA outlook for 2018 is now expected to be slightly down when compared with 2017 pro forma Operating EBITDA as anticipated declines in equity earnings from the HSC Group joint ventures will have an unfavorable impact on the segment with the realignment from Performance Materials & Coatings to Electronics & Imaging. Prior year HSC Group equity earnings included favorable settlements with a customer related to long-term polysilicon sales agreements.

NUTRITION & BIOSCIENCES

The Nutrition & Biosciences segment is an innovation-driven and customer-focused segment that provides solutions for the global food and beverage, pharma, personal care, energy and animal nutrition markets. The segment consists of two operating segments: Nutrition & Health and Industrial Biosciences. The Nutrition & Health business is one of the world's largest producers of specialty food ingredients, developing and manufacturing solutions for the global food and beverage market. The Nutrition & Health business is also one of the world's largest producers of cellulosic- and alginates-based pharma excipients. The Industrial Biosciences business is an industry pioneer and innovator that works with customers to improve the performance, productivity and sustainability of their products and processes through biotechnology and engineering solutions including enzymes, biomaterials, biocides and antimicrobial solutions and process technology.

In millions

Nutrition & Biosciences Three Months Ended Jun 30, 2018 Jun 30, 2017 Six Months Ended Jun 30, 2018 Jun 30, 2017
Net sales $1,775 $277 $3,495 $534
Pro forma net sales $1,494 $2,918
Operating EBITDA $433 $851
Pro forma Operating EBITDA $318 $635
Equity earnings $5 $2 $8 $6
Nutrition & Biosciences Percentage change from prior year Change in Net Sales from Prior Period due to: Three Months Ended Jun 30, 2018 Six Months Ended Jun 30, 2018
Local price & product mix 3% 3%
Currency 3 4
Volume — 4
Portfolio & other 535 543
Total 541% 554%
Change in Net Sales in Current Period from Pro Forma Net Sales in Prior Period due to:
Local price & product mix 1% 1%
Currency 3 4
Volume 4 4
Portfolio & other 11 11
Total 19% 20%

66

Nutrition & Biosciences net sales were $1,775 million in the second quarter of 2018, up from $277 million in the second quarter of 2017. Net sales in the second quarter of 2018 were up 19 percent from pro forma net sales of $1,494 million in the second quarter of 2017. The increase was primarily due to an 11 percent net benefit from portfolio actions due to the acquisition of FMC’s Health & Nutrition business, 4 percent in volume growth, a 3 percent benefit from currency and a 1 percent increase in local price.

Volume growth in the segment was led by Nutrition & Health on improved demand for specialty proteins and continued gains in probiotics and pharmaceutical excipients, primarily in Asia Pacific and U.S. & Canada. Industrial Biosciences volume grew on increased demand for bioactives in animal nutrition and home and personal care applications, coupled with improvement in clean technologies due to alkylation offerings in Asia Pacific and EMEA and acid equipment sales.

Operating EBITDA was $433 million in the second quarter of 2018, up 36 percent compared with pro forma Operating EBITDA of $318 million in the second quarter of 2017, driven by a portfolio benefit, cost synergies, volume growth and lower pension/OPEB costs.

Nutrition & Biosciences net sales were $3,495 million for the first six months of 2018, up from $534 million in the first six months of 2017. Net sales for the first six months of 2018 were up 20 percent from pro forma net sales of $2,918 million in the first six months of 2017. The increase was primarily due to an 11 percent net benefit from portfolio actions due to the acquisition of FMC's Health & Nutrition business, 4 percent in volume growth, a 4 percent benefit from currency and a 1 percent increase in local price.

Volume growth in the segment was led by Nutrition & Health on gains in probiotics, pharmaceutical excipients and specialty proteins driven by demand in Asia Pacific. Industrial Biosciences volume grew on improvement in clean technologies due to alkylation offerings in Asia Pacific and EMEA. Demand for bioactives in animal nutrition and home and personal care applications and microbial solutions in energy markets also contributed to volume growth.

Operating EBITDA was $851 million for the first six months of 2018, up 34 percent from pro forma Operating EBITDA of $635 million in the first six months of 2017, driven by favorable portfolio actions, cost synergies, volume growth and lower pension/OPEB costs, partially offset by higher costs due to growth investments.

TRANSPORTATION & ADVANCED POLYMERS

The Transportation & Advanced Polymers segment provides high-performance engineering resins, adhesives, lubricants and parts to engineers and designers in the transportation, electronics, medical, industrial and consumer end-markets to enable systems solutions for demanding applications and environments. The segment delivers a broad range of polymer-based high-performance materials in its product portfolio, including elastomers and thermoplastic and thermoset engineering polymers which are used by customers to fabricate components for mechanical, chemical and electrical systems. In addition, the segment produces innovative and differentiated adhesive technologies to meet customer specifications for durability, crash performance, and healthcare applications. Transportation & Advanced Polymers also targets the performance plastics and fluid solutions markets by developing technologies that differentiate customers’ products with improved performance characteristics.

In millions

Transportation & Advanced Polymers Three Months Ended Jun 30, 2018 Jun 30, 2017 Six Months Ended Jun 30, 2018 Jun 30, 2017
Net sales $1,468 $298 $2,893 $588
Pro forma net sales $1,284 $2,535
Operating EBITDA $446 $883
Pro forma Operating EBITDA $308 $629
Equity earnings $1 $— $4 $—
Transportation & Advanced Polymers Percentage change from prior year Change in Net Sales from Prior Period due to: Three Months Ended Jun 30, 2018 Six Months Ended Jun 30, 2018
Local price & product mix —% —%
Currency 3 4
Volume 6 3
Portfolio & other 384 385
Total 393% 392%
Change in Net Sales in Current Period from Pro Forma Net Sales in Prior Period due to:
Local price & product mix 5% 5%
Currency 3 4
Volume 6 5
Portfolio & other — —
Total 14% 14%

Transportation & Advanced Polymers net sales were $1,468 million in the second quarter of 2018, up from $298 million in the second quarter of 2017. Net sales in the second quarter of 2018 were up 14 percent from pro forma net sales of $1,284 million in the second quarter of 2017. The increase was due to 6 percent of volume growth, a 5 percent increase in local price and a 3 percent benefit from currency.

Transportation & Advanced Polymers net sales were $2,893 million for the first six months of 2018, up from $588 million in the first six months of 2017. Net sales in the first six months of 2018 were up 14 percent from pro forma net sales of $2,535 million in the first six months of 2017. The increase was due to 5 percent of volume growth, a 5 percent increase in local price and a 4 percent benefit from currency.

Volume growth in the second quarter of 2018 and for the first six months of 2018 was primarily due to performance solutions, led by growth in KALREZ® and VESPEL® high-performance parts in the electronics and aerospace markets, nylon enterprise & polyester due to growth in ZYTEL® and performance resins due to growth in DELRIN® and HYTREL® in the automotive market. Broad-based volume growth was driven by growth in both Asia Pacific and EMEA.

The increase in local price in the second quarter of 2018 and for the first six months of 2018, primarily in nylon enterprise & polyester, was driven by tight polymer supply and higher feedstock costs.

Operating EBITDA was $446 million in the second quarter of 2018, up 45 percent compared with pro forma Operating EBITDA of $308 million in the second quarter of 2017. Operating EBITDA was $883 million for the first six months of 2018, up 40 percent from pro forma Operating EBITDA of $629 million in the first six months of 2017.

The increase in Operating EBITDA in the second quarter of 2018 and the first six months of 2018 was driven by price and volume gains, lower pension/OPEB costs, favorable currency and cost synergies, partially offset by higher raw material costs and increased planned maintenance turnaround activity.

SAFETY & CONSTRUCTION

The Safety & Construction segment is a leading provider of engineered products and integrated systems for a number of industries including construction, worker safety, energy, oil and gas, transportation, medical devices and water purification and separation. The segment satisfies the growing global needs of businesses, governments, and consumers for solutions that make life safer, healthier and better. By uniting market-driven science with the strength of highly regarded brands, the segment strives to bring new products and solutions to solve customers' needs faster, better and more cost effectively. The segment is a leader in safety consulting, selling training products as well as consulting services, to improve the safety, productivity and sustainability of organizations across a range of industries.

In millions

Safety & Construction Three Months Ended Jun 30, 2018 Jun 30, 2017 Six Months Ended Jun 30, 2018 Jun 30, 2017
Net sales $1,411 $490 $2,710 $924
Pro forma net sales $1,329 $2,542
Operating EBITDA $341 $695
Pro forma Operating EBITDA $262 $554
Equity earnings $8 $— $13 $—
Safety & Construction Percentage change from prior year Change in Net Sales from Prior Period due to: Three Months Ended Jun 30, 2018 Six Months Ended Jun 30, 2018
Local price & product mix 1% 1%
Currency 3 3
Volume 3 —
Portfolio & other 181 189
Total 188% 193%
Change in Net Sales in Current Period from Pro Forma Net Sales in Prior Period due to:
Local price & product mix 1% 1%
Currency 2 3
Volume 3 3
Portfolio & other — —
Total 6% 7%

Safety & Construction net sales were $1,411 million in the second quarter of 2018, up from $490 million in the second quarter of 2017. Net sales in the second quarter of 2018 were up 6 percent from pro forma net sales of $1,329 million in the second quarter of 2017 due to 3 percent in volume growth, a 2 percent benefit from currency and a 1 percent increase in local price.

Volume growth was driven by aramids, due to increased sales of NOMEX® thermal-resistant fiber sales into the industrial and aircraft markets, and increased KEVLAR® high-strength materials sales into the life protection and automotive markets. Volume gains in construction were due to end market improvement. The increase in local price was due to price gains across all businesses.

Operating EBITDA was $341 million in the second quarter of 2018, up 30 percent from pro forma Operating EBITDA of $262 million in the second quarter of 2017. Lower pension/OPEB costs, volume growth, cost synergies and favorable currency more than offset higher raw material and freight costs.

Safety & Construction net sales were $2,710 million for the first six months of 2018, up from $924 million in the first six months of 2017. Net sales for the first six months of 2018 were up 7 percent from pro forma net sales of $2,542 million in the first six months of 2017 due to a 3 percent benefit from currency, 3 percent in volume growth and a 1 percent increase in local price.

Volume growth was driven by broad-based demand in industrial applications due to aramids, with strength in NOMEX® and KEVLAR®, as well as gains in TYVEK® enterprise. The increase in local price was due to price gains across most businesses.

Operating EBITDA was $695 million for the first six months of 2018, up 25 percent from pro forma Operating EBITDA of $554 million in the first six months of 2017, due primarily to lower pension/OPEB costs, cost synergies, volume growth and favorable currency, partially offset by higher raw material and freight costs.

CORPORATE

Corporate includes certain enterprise and governance activities (including insurance operations, environmental operations, geographic management, etc.); business incubation platforms; non-business aligned joint ventures; gains and losses on the sales of financial assets; non-business aligned litigation expenses; discontinued or non-aligned businesses and pre-commercial activities.

In millions

Corporate Three Months Ended Jun 30, 2018 Jun 30, 2017 Six Months Ended Jun 30, 2018 Jun 30, 2017
Net sales $75 $96 $151 $167
Pro forma net sales $98 $172
Operating EBITDA $(182) $(351)
Pro forma Operating EBITDA $(190) $(401)
Equity losses $(13) $(11) $(22) $(18)

Net sales for Corporate, which primarily relate to Dow's insurance operations, were $75 million in the second quarter of 2018, compared with net sales of $96 million and pro forma net sales of $98 million in the second quarter of 2017. For the first six months of 2018, net sales were $151 million, compared with net sales of $167 million and pro forma net sales of $172 million in the same period of 2017.

Operating EBITDA was a loss of $182 million in the second quarter of 2018, compared with a pro forma Operating EBITDA loss of $190 million in the second quarter of 2017. In the first six months of 2018, Operating EBITDA was a loss of $351 million compared with a pro forma Operating EBITDA loss of $401 million in the same period last year. Compared with pro forma Operating EBITDA in the first six months of 2017, Operating EBITDA improved primarily due to lower pre-commercial expenses, lower discontinued business costs and cost synergies.

SUPPLEMENTAL DIVISION INFORMATION

Discussion of segment revenue, operating EBITDA and price/volume metrics on a divisional basis for Agriculture is based on the results of the Agriculture segment; for Materials Science is based on the combined results of the Performance Materials & Coatings segment, the Industrial Intermediates & Infrastructure segment and the Packaging & Specialty Plastics segment; and for Specialty Products is based on the combined results of the Electronics & Imaging segment, the Nutrition & Biosciences segment, the Transportation & Advanced Polymers segment and the Safety & Construction segment. The Corporate segment is not included in the division metrics. The segment disclosures have been presented in this manner for informational purposes only and should not be viewed as an indication of each division’s current or future operating results on a standalone basis assuming completion of the Intended Business Separations. See the section entitled “Segment Results” for additional qualitative analysis on segment performance.

In millions

Net Sales by Division Three Months Ended Jun 30, 2018 Jun 30, 2017 1 Six Months Ended Jun 30, 2018 Jun 30, 2017 1
Agriculture $5,730 $4,595 $9,538 $9,644
Performance Materials & Coatings 2,599 2,255 4,903 4,318
Industrial Intermediates & Infrastructure 3,885 3,013 7,600 5,860
Packaging & Specialty Plastics 6,099 5,428 12,109 10,810
Materials Science $12,583 $10,696 $24,612 $20,988
Electronics & Imaging 1,203 1,221 2,356 2,385
Nutrition & Biosciences 1,775 1,494 3,495 2,918
Transportation & Advanced Polymers 1,468 1,284 2,893 2,535
Safety & Construction 1,411 1,329 2,710 2,542
Specialty Products $5,857 $5,328 $11,454 $10,380
Net Sales Variance by Division 1 Local Price & Product Mix Percent change from prior year Three Months Ended Jun 30, 2018 Currency Volume Portfolio / Other 2 Total Local Price & Product Mix Six Months Ended Jun 30, 2018 Currency Volume Portfolio / Other 2 Total
Agriculture 4% 1% 20% —% 25% 2% 2% (5)% —% (1)%
Materials Science 5% 3% 10% —% 18% 5% 4% 8% —% 17%
Specialty Products 1% 3% 4% 2% 10% 2% 3% 3% 2% 10%

In millions

Operating EBITDA by Division Three Months Ended Jun 30, 2018 Jun 30, 2017 1 Six Months Ended Jun 30, 2018 Jun 30, 2017 1
Agriculture $1,685 $1,165 $2,576 $2,626
Performance Materials & Coatings 569 540 1,197 1,021
Industrial Intermediates & Infrastructure 682 417 1,336 929
Packaging & Specialty Plastics 1,330 1,163 2,631 2,277
Materials Science $2,581 $2,120 $5,164 $4,227
Electronics & Imaging 372 410 729 737
Nutrition & Biosciences 433 318 851 635
Transportation & Advanced Polymers 446 308 883 629
Safety & Construction 341 262 695 554
Specialty Products $1,592 $1,298 $3,158 $2,555

1. Information for the three and six months ended June 30, 2017, was prepared on a pro forma basis.

2. Pro forma net sales for Agriculture excludes sales related to the November 30, 2017, divestiture of a portion of the DAS Divested Ag Business for the period January 1, 2017 through June 30, 2017. Pro forma net sales for Materials Science excludes sales related to the September 1, 2017, divestiture of the EAA Business for the period January 1, 2017 through June 30, 2017. Portfolio & Other includes sales for the acquisition of the H&N Business acquired on November 1, 2017, impacting Specialty Products. Portfolio & Other also reflects the following divestitures: SKC Haas Display Films group of companies (divested June 30, 2017), the authentication business (divested on January 6, 2017), and the divestiture of the global food safety diagnostic business (divested February 28, 2017), all impacting Specialty Products.

CHANGES IN FINANCIAL CONDITION

The Company had cash and cash equivalents and marketable securities of $9,751 million at June 30, 2018 and $14,394 million at December 31, 2017, of which $7,141 million at June 30, 2018 and $12,177 million at December 31, 2017, was held by subsidiaries in foreign countries, including United States territories. For each of its foreign subsidiaries, the Company makes an assertion regarding the amount of earnings intended for permanent reinvestment, with the balance available to be repatriated to the United States.

The Company is currently evaluating the impact of The Act on its permanent reinvestment assertion. The Act requires companies to pay a one-time transition tax on earnings of foreign subsidiaries, a majority of which were previously considered permanently reinvested by the Company (see Note 7 to the Consolidated Financial Statements for further details of The Act). A tax liability was accrued for the estimated U.S. federal tax on all unrepatriated earnings at December 31, 2017, in accordance with The Act. The cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries' operational activities and future foreign investments. The Company has the ability to repatriate additional funds to the U.S., which could result in an adjustment to the tax liability for foreign withholding taxes, foreign and/or U.S. state income taxes and the impact of foreign currency movements. During 2018, the Company has and expects to continue repatriating certain funds from its non-U.S. subsidiaries that are not needed to finance local operations or separation activities; however, these particular repatriation activities have not and are not expected to result in a significant incremental tax liability to the Company.

The Company’s cash flows from operating, investing and financing activities, as reflected in the consolidated statements of cash flows, are summarized in the following table. The results for the six months ended June 30, 2017, represent Dow only. The results for the six months ended June 30, 2018, reflect the results of both Dow and DuPont.

In millions

Cash Flow Summary Cash provided by (used for): Six Months Ended Jun 30, 2018 Jun 30, 2017 1
Operating activities $(47) $(101)
Investing activities (390) 192
Financing activities (3,602) (690)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (171) 208
Summary
Decrease in cash, cash equivalents and restricted cash $(4,210) $(391)
Cash, cash equivalents and restricted cash at beginning of period 14,015 6,624
Cash, cash equivalents and restricted cash at end of period $9,805 $6,233

1. Updated for ASU 2016-15 and ASU 2016-18. See Notes 1 and 2 to the Consolidated Financial Statements for additional information.

Reclassification of Prior Period Amounts Related to Accounts Receivable Securitization

In connection with the review and implementation of ASU 2016-15, the Company changed the prior period presentation and amount of proceeds from interests in trade accounts receivable conduits due to additional interpretive guidance related to the required method for calculating the cash received from beneficial interests in the conduits. In the first six months of 2017, changes related to the calculation and presentation of proceeds from interests in trade accounts receivable conduits resulted in a reclassification of $1,914 million from cash used for operating activities to cash provided by investing activities.

Cash Flows from Operating Activities

In the first six months of 2018, cash used for operating activities was $47 million, compared with cash used for operating activities of $101 million in the same period last year. In the first six months of 2018, cash used for working capital requirements, pension contributions and integration and separation costs more than offset increased cash earnings. In the first six months of 2017, cash used for working capital requirements and pension contributions more than offset cash earnings.

In millions

Net Working Capital Jun 30, 2018 Dec 31, 2017
Current assets $47,897 $49,893
Current liabilities 28,110 26,128
Net working capital $19,787 $23,765
Current ratio 1.70:1 1.91:1

72

Cash Flows from Investing Activities

In the first six months of 2018, cash used for investing activities was $390 million, reflecting purchases of investments and capital expenditures, which were partially offset by proceeds from sales and maturities of investments and proceeds from interests in trade accounts receivable conduits. In the first six months of 2017, cash provided by investing activities was $192 million, primarily due to proceeds from interests in trade accounts receivable conduits, proceeds from sales and maturities of investments and net proceeds from sales of property and businesses, which more than offset capital expenditures, loans to Sadara and purchases of investments.

Capital spending was $1,586 million in the first six months of 2018, compared with $1,549 million in the first six months of 2017. The Company expects full year capital spending in 2018 to be approximately $4.2 billion to $4.4 billion. In addition, the Company expects approximately $600 million of additional capital spending for targeted cost synergy and business separation projects by the end of 2018.

In the first six months of 2018, Dow entered into a shareholder loan reduction agreement with Sadara and converted $140 million of the existing loan balance into equity. Dow expects to loan between zero and $200 million to Sadara during the remainder of 2018. All or a portion of the outstanding loans to Sadara could potentially be converted into equity in future periods.

Cash Flows from Financing Activities

In the first six months of 2018, cash used for financing activities was $3,602 million compared with $690 million in the same period last year. The increase was primarily due to purchases of treasury stock, increased payments on long-term debt, increased dividends paid to stockholders and lower proceeds from sales/issuance of common stock, which were partially offset by an increase in notes payable and issuance of long-term debt.

Free Cash Flow

The Company defines free cash flow as cash provided by operating activities less capital expenditures. Under this definition, free cash flow represents the cash that remains available to the Company, after investing in its asset base, to fund obligations using the Company's primary source of incremental liquidity - cash flows from operating activities. Free cash flow is an integral financial measure used in the Company's financial planning process. This financial measure is not recognized in accordance with U.S. GAAP and should not be viewed as an alternative to U.S. GAAP financial measures of performance. All companies do not calculate non-GAAP financial measures in the same manner and, accordingly, the Company's free cash flow definition may not be consistent with the methodologies used by other companies.

For additional information relating to the change in cash used for operating activities, see the discussion above under the section entitled "Cash Flows from Operating Activities."

In millions

Reconciliation of "Cash Used for Operating Activities" to Free Cash Flow Six Months Ended Jun 30, 2018 Jun 30, 2017 1
Cash used for operating activities $(47) $(101)
Capital expenditures (1,586) (1,549)
Free Cash Flow $(1,633) $(1,650)

1. "Cash used for operating activities" was updated for ASU 2016-15 and ASU 2016-18. See Notes 1 and 2 to the Consolidated Financial Statements for additional information.

Liquidity & Financial Flexibility

The Company’s primary source of incremental liquidity is cash flows from operating activities. The generation of cash from operations and each of Dow's and DuPont's (the "Subsidiaries") ability to access the commercial paper market, the long-term debt market, syndicated credit lines, bilateral credit lines and bank financing, including committed repurchase facilities, are expected to meet the Company’s ordinary course cash requirements for working capital, capital expenditures, debt maturities, dividend payments, share repurchases, contributions to pension plans and other needs. The Company’s primary liquidity sources are through the Subsidiaries as discussed below. Management expects that the Company and each of the Subsidiaries will continue to have sufficient liquidity and financial flexibility to meet respective business obligations as they come due.

Dow's Liquidity Sources

Credit Ratings

At July 31, 2018, Dow's credit ratings were as follows:

Credit Ratings Long-Term Rating Short-Term Rating Outlook
Standard & Poor’s BBB A-2 Stable
Moody’s Investors Service Baa2 P-2 Stable
Fitch Ratings BBB F2 Rating Watch Positive

Downgrades in Dow's credit ratings would increase borrowing costs on certain indentures and could impact its ability to access credit markets.

Commercial Paper - Dow

Dow issues promissory notes under U.S. and Euromarket commercial paper programs. At June 30, 2018, Dow had $500 million of commercial paper outstanding ($231 million at December 31, 2017). Dow maintains access to the commercial paper market at competitive rates. Amounts outstanding under Dow's commercial paper programs during the period may be greater, or less, than the amount reported at the end of the period. Subsequent to June 30, 2018, Dow issued approximately $1.1 billion of commercial paper.

Committed Credit Facilities - Dow

In the event the Company has short-term liquidity needs, it can access liquidity through Dow's committed and available credit facilities. On May 27, 2018, Dow renewed a $200 million Bilateral Revolving Credit Facility agreement, which has a maturity date in May 2020 and provides for interest at floating rates, as defined in the agreement. On July 20, 2018, Dow renewed a $200 million Bilateral Revolving Credit Facility agreement, which has a maturity date in July 2020 and provides for interest at floating rates, as defined in the agreement.

In connection with the Dow Silicones ownership restructure, on May 31, 2016, Dow Silicones incurred $4.5 billion of indebtedness under a certain third party credit agreement ("Dow Term Loan Facility"). Dow subsequently guaranteed the obligations of Dow Silicones under the Dow Term Loan Facility and, as a result, the covenants and events of default applicable to the Dow Term Loan Facility are substantially similar to the covenants and events of default set forth in Dow's Five Year Competitive Advance and Revolving Credit Facility. In the second quarter of 2018, Dow Silicones exercised a 19-month extension option making amounts borrowed under the Dow Term Loan Facility repayable on December 30, 2019, and amended the Dow Term Loan Facility to include an additional 2-year extension option, at Dow Silicones' election, upon satisfaction of certain customary conditions precedent.

At June 30, 2018, Dow had total committed credit facilities of $10.9 billion with remaining available credit facilities of $6.4 billion. See Note 15 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2017, for additional information on committed and available credit facilities.

Accounts Receivable Securitization Facilities - Dow

Dow has access to committed accounts receivable securitization facilities in the United States and Europe, from which amounts available for funding are based upon available and eligible accounts receivable within each of the facilities. Dow renewed the United States facility in June 2015, as amended in June 2018, for a term that extends to September 2018. The Europe facility was renewed in July 2015, as amended in June 2018, for a term that extends to October 2018.

In the fourth quarter of 2017, Dow suspended further sales of trade accounts receivable through these facilities and began reducing outstanding balances through collections of trade accounts receivable previously sold to such conduits. Dow has the ability to resume such sales to the conduits, subject to certain prior notice requirements, at the discretion of Dow. See Note 11 to the Consolidated Financial Statements for additional information.

DuPont's Liquidity Sources

Credit Ratings

At July 31, 2018, DuPont's credit ratings were as follows:

Credit Ratings Long-Term Rating Short-Term Rating Outlook
Standard & Poor’s A- A-2 Stable
Moody’s Investors Service A3 P-2 Negative
Fitch Ratings A F1 Rating Watch Negative

Downgrades in DuPont's credit ratings would increase borrowing costs on certain indentures and could impact its ability to access debt capital markets.

Commercial Paper - DuPont

DuPont issues promissory notes under U.S. commercial paper programs. At June 30, 2018, DuPont had $737 million of commercial paper outstanding ($1,436 million at December 31, 2017). DuPont maintains access to the commercial paper market at competitive rates.

Committed Credit Facilities - DuPont

In the event the Company has short-term liquidity needs, it can access liquidity through DuPont's committed and available credit facilities. At June 30, 2018, DuPont had total committed credit facilities of $8.8 billion with remaining available credit facilities of $6.1 billion. See Note 15 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2017, for additional information on committed and available credit facilities.

Term Loan and Revolving Credit Facilities - DuPont

In March 2016, DuPont entered into a credit agreement that provides for a three-year, senior unsecured term loan facility in the aggregate principal amount of $4.5 billion (as may be amended, from time to time, the "Term Loan Facility") under which DuPont may make up to seven term loan borrowings and amounts repaid or prepaid are not available for subsequent borrowings. The proceeds from the borrowings under the Term Loan Facility will be used for DuPont's general corporate purposes including debt repayment, working capital and funding a portion of the Company's costs and expenses. The Term Loan Facility was amended in 2018 to extend the maturity date to June 2020, at which time all outstanding borrowings, including accrued but unpaid interest, become immediately due and payable, and to extend the date on which the commitment to lend terminates to June 2019. At June 30, 2018, DuPont had made three term loan borrowings in an aggregate principal amount of $1.5 billion and had unused commitments of $3.0 billion under the Term Loan Facility. In addition, in 2018, DuPont amended its $3.0 billion revolving credit facility to extend the maturity date to June 2020.

Committed Receivable Repurchase Facility - DuPont

In February 2018, in line with seasonal agricultural working capital requirements, DuPont entered into a committed receivable repurchase agreement of up to $1.3 billion (the "2018 Repurchase Facility") which expires in December 2018. From time to time, DuPont and the banks modify the monthly commitment amounts to better align with working capital requirements. Under the 2018 Repurchase Facility, DuPont may sell a portfolio of available and eligible outstanding customer notes receivables within the Agriculture segment to participating institutions and simultaneously agree to repurchase at a future date. See Note 12 to the Consolidated Financial Statements for additional information.

Debt

The Company’s public debt instruments and primary, private credit agreements (collectively "Debt Instruments") reside with the Subsidiaries. See Note 12 to the Consolidated Financial Statements for information related to the Subsidiaries' notes payable and long-term debt activity since December 31, 2017, including debt retired and issued. The following table reflects the debt of the Subsidiaries:

In millions

Total Debt Jun 30, 2018 Dow DuPont Total Dec 31, 2017 Dow DuPont Total
Notes payable $862 $1,932 $2,794 $484 $1,464 $1,948
Long-term debt due within one year 2,837 1,769 4,606 752 1,315 2,067
Long-term debt 17,122 9,728 26,850 19,765 10,291 30,056
Total debt $20,821 $13,429 $34,250 $21,001 $13,070 $34,071

75

The Debt Instruments of the Subsidiaries contain, among other provisions, certain customary restrictive covenant and default provisions. Dow’s Five Year Competitive Advance and Revolving Credit Facility contains a financial covenant that Dow must maintain its ratio of consolidated indebtedness to its consolidated capitalization at no greater than 0.65 to 1.00 at any time the aggregate outstanding amount of loans under the Five Year Competitive Advance and Revolving Credit Facility equals or exceeds $500 million. The ratio of Dow’s consolidated indebtedness to its consolidated capitalization was 0.42 to 1.00 at June 30, 2018. DuPont’s Term Loan Facility and revolving credit facility contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for DuPont and its consolidated subsidiaries not exceed 0.6667 to 1.00. At June 30, 2018, management believes each of the Subsidiaries were in compliance with all of their respective covenants and default provisions. For additional information on the Subsidiaries' debt covenants and default provisions, see Note 15 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2017.

Dividends

On April 25, 2018, the Company announced that its Board declared a dividend of $0.38 per share, paid on June 15, 2018, to shareholders of record on May 31, 2018. On June 25, 2018, the Company announced that its Board declared a dividend of $0.38 per share, payable on September 14, 2018, to shareholders of record on August 31, 2018.

Share Repurchase Program

On November 2, 2017, the Company announced the Board authorized an initial $4 billion share repurchase program, which has no expiration date. In the first six months of 2018, the Company spent $2 billion on repurchases of DowDuPont common stock under the program. At June 30, 2018, $1 billion of the $4 billion share repurchase program authorization remained available for additional purchases. Although there is no timeline to complete the share repurchase program, subject to sufficient opportunities to be in the market, DowDuPont intends to repurchase approximately $1 billion of the Company's stock in the third quarter of 2018, thereby completing the share repurchase program.

For additional information related to the share repurchase program, see Part II, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Pension Plans

Dow and DuPont did not merge their pension plans and other postretirement benefit plans as a result of the Merger. Dow and DuPont have defined benefit pension plans in the United States and a number of other countries. Dow and DuPont's funding policies are to contribute to defined benefit pension plans in the United States and a number of other countries based on pension funding laws and local currency requirements. Contributions exceeding funding requirements may and have been made at Dow and DuPont's discretion.

DuPont is evaluating making a discretionary contribution in the third quarter of 2018 to its principal U.S. pension plan. Any such contribution could be funded by existing cash balances and/or cash from other available sources of liquidity. The determination to make such a contribution as well as the amount of any such contribution, depends on a number of factors including tax-deductible limits and capital structure considerations. In 2017, DuPont made contributions of $2.9 billion to its principal U.S. pension plan and expects the amount of any contribution made to this plan in 2018 to be less than half of the contributions DuPont made to this plan in 2017.

For additional information regarding Dow and DuPont's pension plans, see Note 16 to the Consolidated Financial Statements and Note 19 to the Consolidated Financial Statements in the Company's Annual Report on Form 10-K for the year ended December 31, 2017.

Restructuring

DowDuPont Cost Synergy Program

The activities related to the DowDuPont Cost Synergy Program ("Synergy Program") are expected to result in additional cash expenditures of approximately $920 million to $1,060 million, primarily by the end of 2019, consisting of severance and related benefit costs and costs associated with exit and disposal activities, including environmental remediation (see Note 5 to the Consolidated Financial Statements). The Synergy Program includes certain asset actions that are reflected in the preliminary fair value measurement of DuPont’s assets as of the Merger date. Current estimated total pretax restructuring charges could be impacted by future adjustments to the preliminary fair value of DuPont’s assets. The Company expects to incur additional costs in the future related to its restructuring activities. Future costs are expected to include demolition costs related to closed facilities and restructuring plan implementation costs; these costs will be recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary termination benefits, related to its other optimization activities. These costs cannot be reasonably estimated at this time.

Contractual Obligations

Information related to the Company’s contractual obligations, commercial commitments and expected cash requirements for interest can be found in the Company's 2017 Annual Report on Form 10-K, Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, Liquidity and Capital Resources. Additional information related to these obligations can be found in Notes 15, 16 and 19 to the Consolidated Financial Statements in the Company’s 2017 Annual Report on Form 10-K. With the exception of the item noted below, there have been no material changes in the Company’s contractual obligations since December 31, 2017.

In millions

Contractual Obligations Payments Due In 2018 2019-2020 2021-2022 2023 and beyond Total
Purchase obligations 1 $4,058 $6,000 $4,699 $7,551 $22,308

1. Includes take-or-pay and throughput obligations and outstanding purchase orders and other commitments greater than $1 million, obtained through a survey conducted by the Subsidiaries.

Off-balance Sheet Arrangements

Off-balance sheet arrangements are obligations the Company has with nonconsolidated entities related to transactions, agreements or other contractual arrangements. The Company holds variable interests in joint ventures accounted for under the equity method of accounting. The Company is not the primary beneficiary of these joint ventures and therefore is not required to consolidate the entities (see Note 20 to the Consolidated Financial Statements). In addition, see Note 11 to the Consolidated Financial Statements for information regarding the transfer of financial assets.

Guarantees arise in the ordinary course of business from relationships with customers and nonconsolidated affiliates when the Subsidiaries undertake an obligation to guarantee the performance of others if specific triggering events occur. The Subsidiaries had combined outstanding guarantees at June 30, 2018, of $5,759 million, compared with $5,960 million at December 31, 2017. Additional information related to the guarantees of the Subsidiaries can be found in the “Guarantees” section of Note 13 to the Consolidated Financial Statements.

Fair Value Measurements

See Note 19 to the Consolidated Financial Statements for additional information concerning fair value measurements.

OTHER MATTERS

Recent Accounting Guidance

See Note 2 to the Consolidated Financial Statements for a summary of recent accounting guidance.

Critical Accounting Estimates

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make judgments, assumptions and estimates that affect the amounts reported in the consolidated financial statements and accompanying notes. Note 1 to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 (“2017 10-K”) describes the significant accounting policies and methods used in the preparation of the consolidated financial statements. DowDuPont’s accounting policies that are impacted by judgments, assumptions and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s 2017 10-K. Since December 31, 2017, there have been no material changes in the Company’s accounting policies that are impacted by judgments, assumptions and estimates.

Asbestos-Related Matters of Union Carbide Corporation

Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past four decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem. In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products.

The table below provides information regarding asbestos-related claims pending against Union Carbide and Amchem based on criteria developed by Union Carbide and its external consultants.

Asbestos-Related Claim Activity 2018 2017
Claims unresolved at Jan 1 15,427 16,141
Claims filed 3,537 3,644
Claims settled, dismissed or otherwise resolved (5,230) (3,875)
Claims unresolved at Jun 30 13,734 15,910
Claimants with claims against both Union Carbide and Amchem (4,928) (5,648)
Individual claimants at Jun 30 8,806 10,262

Plaintiffs’ lawyers often sue numerous defendants in individual lawsuits or on behalf of numerous claimants. As a result, the damages alleged are not expressly identified as to Union Carbide, Amchem or any other particular defendant, even when specific damages are alleged with respect to a specific disease or injury. In fact, there are no personal injury cases in which only Union Carbide and/or Amchem are the sole named defendants. For these reasons and based upon Union Carbide’s litigation and settlement experience, Union Carbide does not consider the damages alleged against Union Carbide and Amchem to be a meaningful factor in its determination of any potential asbestos-related liability.

For additional information, see Asbestos-Related Matters of Union Carbide Corporation in Note 13 to the Consolidated Financial Statements and Part II, Item 1. Legal Proceedings.

Valuation of Assets and Impairment Considerations

As a result of the Merger and the related acquisition method of accounting, DuPont’s assets and liabilities were measured at fair value, and any declines in projected cash flows could have a material, negative impact on the fair value of the Company’s reporting units and assets, particularly within the Agriculture and Specialty Products divisions, and therefore could result in an impairment. During the third quarter of 2018, strategic business reviews will commence with the focus on alignment of the businesses to the Company’s overall growth strategy which includes a focus on core business offerings and higher margin product lines. Strategic decisions resulting from these reviews will be considered and could result in changes to the factors and assumptions used to determine the fair value of the Company’s reporting units and indefinite-lived intangible assets from those made in the purchase accounting from the Merger and the 2017 annual impairment testing process. Changes to those assumptions could significantly impact the results of goodwill and indefinite-lived intangible assets impairment testing including a potential third quarter impairment.

Market risk

As filed, 316 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

See Note 18 to the Consolidated Financial Statements. See also Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk, of the Company's 2017 Annual Report on Form 10-K for information on the Company's utilization of financial instruments and an analysis of the sensitivity of these instruments.

Controls and procedures

As filed, 1,169 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, the Company carried out an evaluation, under the supervision and with the participation of the Company’s Disclosure Committee and the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to paragraph (b) of Exchange Act Rules 13a-15 and 15d-15. Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

There were no changes in the Company's internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that was conducted during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

DowDuPont Inc. PART II - OTHER INFORMATION

Risk factors

As filed, 191 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes in the Company's risk factors discussed in Part I, Item 1A, Risk Factors, in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue3 months2018-04-01 to 2018-06-30$17.97bnus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2018-01-01 to 2018-06-30$34.29bnus-gaap:CostOfGoodsAndServicesSold
Research and development3 months2018-04-01 to 2018-06-30$803.0mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2018-01-01 to 2018-06-30$1.57bnus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2018-04-01 to 2018-06-30$1.93bnus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2018-01-01 to 2018-06-30$3.65bnus-gaap:SellingGeneralAndAdministrativeExpense
Income tax3 months2018-04-01 to 2018-06-30$565.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2018-01-01 to 2018-06-30$954.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2018-04-01 to 2018-06-30$1.77bnus-gaap:NetIncomeLoss
Net income6 months2018-01-01 to 2018-06-30$2.87bnus-gaap:NetIncomeLoss
Diluted EPS3 months2018-04-01 to 2018-06-30$0.76us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2018-01-01 to 2018-06-30$1.23us-gaap:EarningsPerShareDiluted
Basic EPS3 months2018-04-01 to 2018-06-30$0.76us-gaap:EarningsPerShareBasic
Basic EPS6 months2018-01-01 to 2018-06-30$1.24us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2018-04-01 to 2018-06-302,323,600,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2018-01-01 to 2018-06-302,329,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2018-01-01 to 2018-06-30−$47.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2018-04-01 to 2018-06-30$810.0mus-gaap:PaymentsToAcquireProductiveAssets
Capital expenditure6 months2018-01-01 to 2018-06-30$1.59bnus-gaap:PaymentsToAcquireProductiveAssets
Dividends paid6 months2018-01-01 to 2018-06-30$1.75bnus-gaap:PaymentsOfDividends
Share repurchases6 months2018-01-01 to 2018-06-30$2.00bnus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2018-06-30$9.24bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-06-30$47.90bnus-gaap:AssetsCurrent
Total assetsAt period end2018-06-30$187.37bnus-gaap:Assets
Current liabilitiesAt period end2018-06-30$28.11bnus-gaap:LiabilitiesCurrent
Long-term debtAt period end2018-06-30$31.46bnus-gaap:LongTermDebt
Shareholders' equityAt period end2018-06-30$98.26bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001666700-18-000041. Last ingested by Listed: Nov 10, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.